TG Therapeutics Inc (NASDAQ:TGTX)
| 5.16 Delayed Data As of May 27 |  +0.11 / +2.18%Today’s Change | 4.73 Today|||52-Week Range 41.00 | -72.84% Year-to-Date |
Latest TGTX News | Press Releases
| Time to Weed Your Holdings and Upgrade Your Portfolio May 23 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 5.05 |
| Today’s open | 5.01 |
| Day’s range | 4.77 - 5.25 |
| Volume | 335,250 |
| Average volume (3 months) | 2,744,071 |
| Market cap | $778.5M |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -8.68% |
| Earnings growth (this year) | +23.19% |
| Earnings growth (next 5 years) | -57.11% |
| Revenue growth (last year) | +4,300.66% |
| P/E ratio | NM |
| Price/Sales | 375.58 |
| Price/Book | 3.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CPRXCatalyst Pharmaceuti... | +0.31 | +4.42% |
| PAHCPhibro Animal Health... | +0.49 | +2.58% |
| TBPHTheravance Biopharma... | +0.32 | +3.59% |
| MIRMMirum Pharmaceutical... | +0.24 | +0.98% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | May 30, 2022 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $6.7M |
| Annual profit (last year) | -$348.1M |
| Net profit margin | -5,204.08% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
